Explore By Subject Area   

Lead Editorial

Coherus Chief Development Officer on Next Steps in Toripalimab Drug Development

Coherus Chief Development Officer on Next Steps in Toripalimab Drug Development

Theresa LaVallee, PhD, is the Chief Development Officer of Coherus, and recently shepherded their drug toripalimab through a challenging approval process. She tells us what is next for the drug, the challenges facing medicine developers, and what keeps her enthusiastic about immuno-oncology.

Read More

More Related Content

Editorial

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.